IRCT20120817010617N5已完成3 期
Intralesional administration of interferon alfa 2-b in treatment of pterygium
Zahedan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •patients with pure Pterygium that involve at least 1mm cornea based on clinical diagnosis
排除标准
- •Any eye pathology other than pterygium
研究者
相似试验
招募中
不适用
Combination therapy of interferon-alpha and interleukin-2 for patients with metastatic renal cell carcinoma after failure of targeted therapy because of adverse eventsJPRN-UMIN000017717Department of Urology, The University of Tokyo Hospital30
尚未招募
4 期
ocal injections versus eyedrops Interferon in ocular surface squamous neoplasiaCTRI/2024/03/064353Dr Rajendra Prasad Centre of Ophthalmic Sciences
进行中（未招募）
不适用
Treatment with leucocytic interferon-alpha more ribavirine towards peg-interferon to reduced doses more ribavirine in patients affections from positive chronic hepatitis HCV that in course of arranged therapy demand the reduction of the peghilato dosage of interferon. - NDEUCTR2005-005161-11-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI200
已完成
2 期
The efficacy of topical interferon alpha-2b in pterygiumpterygium.Pterygium of eyeH11.0IRCT20190806044463N1Bagheiat-allah University of Medical Sciences18
已完成
2 期
Recombinant interferon alpha-2b in paranoid schizophrenia.RPCEC00000067Center for Genetic Engineering and Biotechnology (CIGB), Havana City.60